Professional Records
License Records
Mary C Garry
License #:
RS099110A - Expired
Category:
Real Estate Commission
Type:
Real Estate Salesperson-Standard
Mary Garry Phones & Addresses
-
Forney, TX
-
Garland, TX
-
Wylie, TX
-
Plano, TX
-
Grapevine, TX
-
Arlington, TX
-
Irving, TX
Business Records
Name / Title
Company / Classification
Phones & Addresses
Secretary, Director
PROMETHEUS SCIENTIFIC INC
4215 Nashwood Ln, Dallas, TX 75244
4215 Nashwood Land, Dallas, TX 75244
4215 Nashwood Land, Dallas, TX 75244
Publications
Us Patents
Peptides Of Cav2.2 That Inhibit Pain
View pageUS Patent:
7829688, Nov 9, 2010
Filed:
Aug 12, 2008
Appl. No.:
12/190459
Inventors:
Mary Garry - Dallas TX, US
Ilya Bezprozvanny - Dallas TX, US
Ilya Bezprozvanny - Dallas TX, US
Assignee:
The Board of Regents of the University of Texas System - Austin TX
International Classification:
C07H 21/00
C40B 40/06
C40B 40/06
US Classification:
536 235, 506 16, 506 17, 536 234
Abstract:
The present invention relates to peptides of CaV2. 2 and their use in the treatment of pain. The sequence of the peptides is derived from the C-terminus of CaV2. 2. and is believed to inhibit the interaction of CaV2. 2 with Mint1-PDZ1. The invention is related to use of this peptide to treat pain and to use of this peptide in binding reaction with int-PDZ to screen for small molecules that can inhibit pain.
Peptides Of Cav2.2 That Inhibit Pain
View pageUS Patent:
20050267036, Dec 1, 2005
Filed:
Mar 31, 2005
Appl. No.:
11/096281
Inventors:
Mary Garry - Dallas TX, US
Ilya Bezprozvanny - Dallas TX, US
Ilya Bezprozvanny - Dallas TX, US
International Classification:
A61K038/10
A61K038/08
A61K038/06
C07K007/06
C07K007/08
A61K038/08
A61K038/06
C07K007/06
C07K007/08
US Classification:
514016000, 514017000, 514018000, 530329000, 530330000
Abstract:
The present invention relates to peptides of CaV2.2 and their use in the treatment of pain. The sequence of the peptides is derived from the C-terminus of CaV2.2. and is believed to inhibit the interaction of CaV2.2 with Mint1-PDZ1. The invention is related to use of this peptide to treat pain and to use of this peptide in binding reaction with int-PDZ to screen for small molecules that can inhibit pain.